New Technology will Ensure Safety of Chemotherapy Drugs for Manitobans Who Need Them
IH Systems RIVA technology will prepare chemotherapy drugs with a high degree of precision that will help CancerCare Manitoba enhance patient and staff safety
IH Systems RIVA technology will prepare chemotherapy drugs with a high degree of precision that will help CancerCare Manitoba enhance patient and staff safety
XiteBio Technologies Inc. is pleased to announce the registration of XiteBio® SoyRhizo® soybean inoculant for the Canadian market by the Canadian Food Inspection Agency (CFIA).
Manitoba's life sciences industry needs better access to capital, more business from customers in the home market and a larger pool of professional management to draw from.
In 2012, LSAM and Deloitte surveyed leaders of life science companies located in Manitoba. The results are now available online.
Valeant has confirmed it's buying Bausch + Lomb Holdings in a deal that will boost the Canadian drug maker's presence in the eye-care sector.
Canadian-made StrixNB™ scientifically proven to improve oral health
U of M researchers will receive $9.5 million in new funding for grants and scholarships from NSERC over the next five years.
More than 2,890 hospital patients in Canada are infected with a so-called “superbug,” or an antibiotic-resistant organism, at any one time, according to new Canadian research.
Dr. Joel Kettner, of the International Centre for Infectious Diseases in Winni
"The court's ruling today ensures that longstanding principles of patent law apply to breakthrough 21st century technologies that are central to meeting the growing demands of our planet and its people
"This is a transformational moment for the health of women and girls across the world," said Dr. Seth Berkley, CEO of GAVI, which is short for Global Alliance for Vaccines and Immunization.
Of the 55 projects being supported, 15 will be pre-commercialisation demonstration projects to test the feasibility of various technologies, and 40 will be research and development projects to address knowledge gaps and bring technologies from the concept
“These devices are designed to provide optimal therapy for patients, while providing economic benefits through fewer hospitalizations, fewer inappropriate shocks, and increased longevity.”
Manitoba Agri-Health Research Network, Inc. (MAHRN) and Minnesota-based TruHealthMD have signed a Memorandum of Understanding that will more rapidly advance the development and commercialization of condition specific food and nutrition therapies.
New federal-provincial/territorial cost-shared programs
designed to help position Canada as a world leader in agriculture and agri-food
Manitoba bio-entrepreneur Dr. Albert D. Friesen wins prestigious Industry Leadership Gold Leaf Award from BIOTECanada.
The NeuroBlate thermal therapy system, developed by Monteris Medical provides a safe procedure for treating recurrent malignant type of brain tumor.
Medtronic announced market release of the CardioGuide™ Implant System, a novel real-time navigation system for cardiac resynchronization therapy pacemakers and defibrillators.
Conviron announced it has acquired White Rock, B.C.-based Argus Control Systems Ltd.
Monteris Medical has received Health Canada clearance to make its MRI-guided, minimally invasive surgical laser device commercially available in Canada.
Kane Biotech showed StrixNB was very effective against halitosis bad breath in Sheltie dogs.
Kane Biotech announced it has appointed Pacific Veterinary Sales of Abbotsford, B.C. as a distribution partner for the upcoming StrixNB pet oral care product launch in Western Canada.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.